252 related articles for article (PubMed ID: 27399327)
1. Percutaneous CT-guided Radiofrequency Ablation for Lymph Node Oligometastases from Hepatocellular Carcinoma: A Propensity Score-matching Analysis.
Pan T; Xie QK; Lv N; Li XS; Mu LW; Wu PH; Zhao M
Radiology; 2017 Jan; 282(1):259-270. PubMed ID: 27399327
[TBL] [Abstract][Full Text] [Related]
2. Percutaneous CT-guided radiofrequency ablation for patients with extrahepatic oligometastases of hepatocellular carcinoma: long-term results.
Mu L; Sun L; Pan T; Lyu N; Li S; Li X; Wang J; Xie Q; Deng H; Zheng L; Peng J; Shen L; Fan W; Wu P; Zhao M
Int J Hyperthermia; 2018 Feb; 34(1):59-67. PubMed ID: 28540809
[TBL] [Abstract][Full Text] [Related]
3. [Efficacy of radiofrequency ablation to treat advanced hepatocellular carcinoma].
Wu J; Chen MH; Yang W; Wu W; Yan K
Zhonghua Gan Zang Bing Za Zhi; 2012 Apr; 20(4):256-60. PubMed ID: 22964144
[TBL] [Abstract][Full Text] [Related]
4. Hepatocellular carcinoma: concomitant sorafenib promotes necrosis after radiofrequency ablation--propensity score matching analysis.
Fukuda H; Numata K; Moriya S; Shimoyama Y; Ishii T; Nozaki A; Kondo M; Morimoto M; Maeda S; Sakamaki K; Morita S; Tanaka K
Radiology; 2014 Aug; 272(2):598-604. PubMed ID: 24689883
[TBL] [Abstract][Full Text] [Related]
5. Comparison of combined transcatheter arterial chemoembolization and radiofrequency ablation with surgical resection by using propensity score matching in patients with hepatocellular carcinoma within Milan criteria.
Takuma Y; Takabatake H; Morimoto Y; Toshikuni N; Kayahara T; Makino Y; Yamamoto H
Radiology; 2013 Dec; 269(3):927-37. PubMed ID: 24086071
[TBL] [Abstract][Full Text] [Related]
6. Early-stage hepatocellular carcinoma in patients with cirrhosis: long-term results of percutaneous image-guided radiofrequency ablation.
Lencioni R; Cioni D; Crocetti L; Franchini C; Pina CD; Lera J; Bartolozzi C
Radiology; 2005 Mar; 234(3):961-7. PubMed ID: 15665226
[TBL] [Abstract][Full Text] [Related]
7. Long-term Therapeutic Outcomes of Radiofrequency Ablation for Subcapsular versus Nonsubcapsular Hepatocellular Carcinoma: A Propensity Score Matched Study.
Kang TW; Lim HK; Lee MW; Kim YS; Rhim H; Lee WJ; Paik YH; Kim MJ; Ahn JH
Radiology; 2016 Jul; 280(1):300-12. PubMed ID: 26824711
[TBL] [Abstract][Full Text] [Related]
8. Safety and technical feasibility of percutaneous ablation for lymph node metastases of hepatocellular carcinoma.
Yuan Z; Xing A; Zheng J; Li W
Int J Hyperthermia; 2019 Jan; 36(1):160-168. PubMed ID: 30776925
[TBL] [Abstract][Full Text] [Related]
9. Comparison of transarterial chemoembolization with radiofrequency ablation for unresectable Barcelona Clinic Liver Cancer stage 0/A hepatocellular carcinoma: a propensity score matching.
Chen RX; Gan YH; Ge NL; Chen Y; Ma H; Wang Y; Zhang BH; Wang YH; Ye SL; Luo JF; Ren ZG
J Gastroenterol Hepatol; 2016 Feb; 31(2):442-9. PubMed ID: 26259976
[TBL] [Abstract][Full Text] [Related]
10. Hepatocellular carcinoma treated with radiofrequency ablation with or without ethanol injection: a prospective randomized trial.
Zhang YJ; Liang HH; Chen MS; Guo RP; Li JQ; Zheng Y; Zhang YQ; Lau WY
Radiology; 2007 Aug; 244(2):599-607. PubMed ID: 17641378
[TBL] [Abstract][Full Text] [Related]
11. Effectiveness and safety in radiofrequency ablation of pulmonary metastases from HCC: a five years study.
Lassandro G; Picchi SG; Bianco A; Di Costanzo G; Coppola A; Ierardi AM; Lassandro F
Med Oncol; 2020 Mar; 37(4):25. PubMed ID: 32166529
[TBL] [Abstract][Full Text] [Related]
12. CT-guided radiofrequency ablation after with transarterial chemoembolization in treating unresectable hepatocellular carcinoma with long overall survival improvement.
Zhao M; Wang JP; Pan CC; Li W; Huang ZL; Zhang L; Fang WJ; Jiang Y; Li XS; Wu PH
Eur J Radiol; 2012 Oct; 81(10):2717-25. PubMed ID: 22245655
[TBL] [Abstract][Full Text] [Related]
13. Comparison of percutaneous radiofrequency ablation and CyberKnife(®) for initial solitary hepatocellular carcinoma: A pilot study.
Shiozawa K; Watanabe M; Ikehara T; Matsukiyo Y; Kogame M; Kishimoto Y; Okubo Y; Makino H; Tsukamoto N; Igarashi Y; Sumino Y
World J Gastroenterol; 2015 Dec; 21(48):13490-9. PubMed ID: 26730160
[TBL] [Abstract][Full Text] [Related]
14. Radiofrequency ablation versus hepatic resection for the treatment of hepatocellular carcinomas 2 cm or smaller: a retrospective comparative study.
Peng ZW; Lin XJ; Zhang YJ; Liang HH; Guo RP; Shi M; Chen MS
Radiology; 2012 Mar; 262(3):1022-33. PubMed ID: 22357902
[TBL] [Abstract][Full Text] [Related]
15. Thermal Injury-induced Hepatic Parenchymal Hypoperfusion: Risk of Hepatocellular Carcinoma Recurrence after Radiofrequency Ablation.
Lee DH; Lee JM; Yoon JH; Kim YJ; Han JK
Radiology; 2017 Mar; 282(3):880-891. PubMed ID: 27643670
[TBL] [Abstract][Full Text] [Related]
16. Radiofrequency ablation of hepatocellular carcinoma in difficult locations: Strategies and long-term outcomes.
Yang W; Yan K; Wu GX; Wu W; Fu Y; Lee JC; Zhang ZY; Wang S; Chen MH
World J Gastroenterol; 2015 Feb; 21(5):1554-66. PubMed ID: 25663774
[TBL] [Abstract][Full Text] [Related]
17. First-line radiofrequency ablation with or without artificial ascites for hepatocellular carcinomas in a subcapsular location: local control rate and risk of peritoneal seeding at long-term follow-up.
Kang TW; Lim HK; Lee MW; Kim YS; Choi D; Rhim H
Clin Radiol; 2013 Dec; 68(12):e641-51. PubMed ID: 23973161
[TBL] [Abstract][Full Text] [Related]
18. [Transarterial chemoembolization plus computed tomography-guided percutaneous radiofrequency ablation for small hepatocellular carcinoma in special locations].
Guo YJ; Huang WS; Zhou B; Chen JW; Cai MY; Qian JS; Huang MS; Shan H; Zhu KS
Zhonghua Yi Xue Za Zhi; 2013 Sep; 93(33):2627-30. PubMed ID: 24360041
[TBL] [Abstract][Full Text] [Related]
19. Ultrasonography-guided percutaneous radiofrequency ablation of hepatocellular carcinomas: a feasibility scoring system for planning sonography.
Rhim H; Choi D; Kim YS; Lim HK; Choe BK
Eur J Radiol; 2010 Aug; 75(2):253-8. PubMed ID: 19427152
[TBL] [Abstract][Full Text] [Related]
20. CT-Guided Radiofrequency Ablation of T1a Renal Cell Carcinoma in Korea: Mid-Term Outcomes.
Kim HJ; Park BK; Park JJ; Kim CK
Korean J Radiol; 2016; 17(5):763-70. PubMed ID: 27587966
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]